Skip to main content
PMC home page
The BMJ logoLink to The BMJ
. 1991 Nov 16;303(6812):1225–1228. doi: 10.1136/bmj.303.6812.1225

Diagnosis of susceptibility to malignant hyperthermia with flanking DNA markers.

S J Healy 1, J J Heffron 1, M Lehane 1, D G Bradley 1, K Johnson 1, T V McCarthy 1
PMCID: PMC1671561  PMID: 1684123

Abstract

OBJECTIVE--To define the region on human chromosome 19 carrying the gene for malignant hyperthermia susceptibility and to evaluate the use of flanking DNA markers in diagnosing susceptibility. DESIGN--Prospective molecular genetic linkage studies in a large malignant hyperthermia pedigree. SETTING--Irish malignant hyperthermia testing centre. SUBJECTS--A large Irish malignant hyperthermia pedigree. MAIN OUTCOME MEASURES--Routine diagnosis of susceptibility to malignant hyperthermia with in vitro contracture test on muscle biopsy specimens and genetic linkage between susceptibility and polymorphic DNA markers in a malignant hyperthermia family. RESULTS--Genetic typing of polymorphic DNA markers in a large Irish malignant hyperthermia pedigree generated a lod score of greater than 3 for the marker D19S9 and showed that the gene for susceptibility is flanked by the markers D19S9 and D19S16. These tightly linked flanking markers allowed non-invasive presymptomatic diagnosis of susceptibility in five untested subjects in the large pedigree with an accuracy of greater than 99.7%. CONCLUSIONS--DNA markers flanking the gene for susceptibility to malignant hyperthermia can be used with high accuracy to diagnose susceptibility in subjects in large known malignant hyperthermia pedigrees and may replace the previous in vitro contracture test for diagnosing this inherited disorder in large families with malignant hyperthermia.

Full text

PDF
1225

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Britt B. A., Kalow W. Malignant hyperthermia: a statistical review. Can Anaesth Soc J. 1970 Jul;17(4):293–315. doi: 10.1007/BF03004694. [DOI] [PubMed] [Google Scholar]
  2. Britt B. A., Locher W. G., Kalow W. Hereditary aspects of malignant hyperthermia. Can Anaesth Soc J. 1969 Mar;16(2):89–98. doi: 10.1007/BF03005788. [DOI] [PubMed] [Google Scholar]
  3. Brook J. D., Shaw D. J., Meredith L., Bruns G. A., Harper P. S. Localisation of genetic markers and orientation of the linkage group on chromosome 19. Hum Genet. 1984;68(4):282–285. doi: 10.1007/BF00292584. [DOI] [PubMed] [Google Scholar]
  4. Brunner H. G., Smeets H., Lambermon H. M., Coerwinkel-Driessen M., van Oost B. A., Wieringa B., Ropers H. H. A multipoint linkage map around the locus for myotonic dystrophy on chromosome 19. Genomics. 1989 Oct;5(3):589–595. doi: 10.1016/0888-7543(89)90027-x. [DOI] [PubMed] [Google Scholar]
  5. Feinberg A. P., Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem. 1983 Jul 1;132(1):6–13. doi: 10.1016/0003-2697(83)90418-9. [DOI] [PubMed] [Google Scholar]
  6. Heffron J. J. Malignant hyperthermia: biochemical aspects of the acute episode. Br J Anaesth. 1988 Feb;60(3):274–278. doi: 10.1093/bja/60.3.274. [DOI] [PubMed] [Google Scholar]
  7. Humphries S. E., Jowett N. I., Williams L., Rees A., Vella M., Kessling A., Myklebost O., Lydon A., Seed M., Galton D. J. A DNA polymorphism adjacent to the human apolipoprotein CII gene. Mol Biol Med. 1983 Dec;1(5):463–471. [PubMed] [Google Scholar]
  8. Iaizzo P. A., Klein W., Lehmann-Horn F. Fura-2 detected myoplasmic calcium and its correlation with contracture force in skeletal muscle from normal and malignant hyperthermia susceptible pigs. Pflugers Arch. 1988 Jun;411(6):648–653. doi: 10.1007/BF00580861. [DOI] [PubMed] [Google Scholar]
  9. Lathrop G. M., Lalouel J. M., Julier C., Ott J. Strategies for multilocus linkage analysis in humans. Proc Natl Acad Sci U S A. 1984 Jun;81(11):3443–3446. doi: 10.1073/pnas.81.11.3443. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Levitt R. C., McKusick V. A., Fletcher J. E., Rosenberg H. Gene candidate. Nature. 1990 May 24;345(6273):297–298. doi: 10.1038/345297b0. [DOI] [PubMed] [Google Scholar]
  11. López J. R., Alamo L., Caputo C., Wikinski J., Ledezma D. Intracellular ionized calcium concentration in muscles from humans with malignant hyperthermia. Muscle Nerve. 1985 Jun;8(5):355–358. doi: 10.1002/mus.880080502. [DOI] [PubMed] [Google Scholar]
  12. MacKenzie A. E., Korneluk R. G., Zorzato F., Fujii J., Phillips M., Iles D., Wieringa B., Leblond S., Bailly J., Willard H. F. The human ryanodine receptor gene: its mapping to 19q13.1, placement in a chromosome 19 linkage group, and exclusion as the gene causing myotonic dystrophy. Am J Hum Genet. 1990 Jun;46(6):1082–1089. [PMC free article] [PubMed] [Google Scholar]
  13. MacLennan D. H., Duff C., Zorzato F., Fujii J., Phillips M., Korneluk R. G., Frodis W., Britt B. A., Worton R. G. Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia. Nature. 1990 Feb 8;343(6258):559–561. doi: 10.1038/343559a0. [DOI] [PubMed] [Google Scholar]
  14. McCarthy T. V., Healy J. M., Heffron J. J., Lehane M., Deufel T., Lehmann-Horn F., Farrall M., Johnson K. Localization of the malignant hyperthermia susceptibility locus to human chromosome 19q12-13.2. Nature. 1990 Feb 8;343(6258):562–564. doi: 10.1038/343562a0. [DOI] [PubMed] [Google Scholar]
  15. McCarthy T. V., Healy J. M., Lehane M., Heffron J. J. Recent developments in the molecular genetics of malignant hyperthermia: implications for future diagnosis at the DNA level. Acta Anaesthesiol Belg. 1990;41(2):107–112. [PubMed] [Google Scholar]
  16. Mickelson J. R., Gallant E. M., Litterer L. A., Johnson K. M., Rempel W. E., Louis C. F. Abnormal sarcoplasmic reticulum ryanodine receptor in malignant hyperthermia. J Biol Chem. 1988 Jul 5;263(19):9310–9315. [PubMed] [Google Scholar]
  17. Nelson T. E. Abnormality in calcium release from skeletal sarcoplasmic reticulum of pigs susceptible to malignant hyperthermia. J Clin Invest. 1983 Sep;72(3):862–870. doi: 10.1172/JCI111057. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Ohnishi S. T., Taylor S., Gronert G. A. Calcium-induced Ca2+ release from sarcoplasmic reticulum of pigs susceptible to malignant hyperthermia. The effects of halothane and dantrolene. FEBS Lett. 1983 Sep 5;161(1):103–107. doi: 10.1016/0014-5793(83)80739-x. [DOI] [PubMed] [Google Scholar]
  19. Ropers H. H., Pericak-Vance M. A. Report of the committee on the genetic constitution of chromosome 19. Cytogenet Cell Genet. 1990;55(1-4):218–228. doi: 10.1159/000133015. [DOI] [PubMed] [Google Scholar]
  20. Schepens J., Smeets H., Hulsebos T., Brunner H., Wieringa B. Isolation of a polymorphic DNA sequence pJSB11 (D19S16) from the human chromosome 19cen-q13.2 region linked to the myotonic dystrophy (DM) gene. Nucleic Acids Res. 1987 Apr 10;15(7):3192–3192. doi: 10.1093/nar/15.7.3192. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Schonk D., Coerwinkel-Driessen M., van Dalen I., Oerlemans F., Smeets B., Schepens J., Hulsebos T., Cockburn D., Boyd Y., Davis M. Definition of subchromosomal intervals around the myotonic dystrophy gene region at 19q. Genomics. 1989 Apr;4(3):384–396. doi: 10.1016/0888-7543(89)90346-7. [DOI] [PubMed] [Google Scholar]
  22. Wainwright B. J., Watson E. K., Shephard E. A., Phillips I. R. RFLP for a human cytochrome P-450 gene at 19q13.1-qter (HGM8 provisional designation CYPI). Nucleic Acids Res. 1985 Jun 25;13(12):4610–4610. doi: 10.1093/nar/13.12.4610. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES